Analysis of HIV latent infection model with multiple infection stages and different drug classes
From MaRDI portal
Publication:5052707
DOI10.1080/17513758.2022.2113828zbMath1505.92184OpenAlexW4306912451MaRDI QIDQ5052707
Nidal al-Hosainat, Areej Alshorman, Trachette L. Jackson
Publication date: 25 November 2022
Published in: Journal of Biological Dynamics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/17513758.2022.2113828
stabilityentry inhibitorsHIV infection stageshomeostatic proliferation of latently infected cellslatently infected CD\(4^+\)T cells
Cites Work
- Dynamics of an HIV model with multiple infection stages and treatment with different drug classes
- A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- On the definition and the computation of the basic reproduction ratio \(R_ 0\) in models for infectious diseases in heterogeneous populations
- Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs?
- Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: the role of fusion inhibitors in HAART
- Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips
- The differential infectivity and staged progression models for the transmission of HIV
- Modeling HIV persistence, the latent reservoir, and viral blips
- Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV
- The reproductive number for an HIV model with differential infectivity and staged progression
- Dynamics of HIV infection of CD4\(^ +\) T cells
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy
- Dynamics of a new HIV model with the activation status of infected cells
- Dynamics of two time delays differential equation model to HIV latent infection
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach
- Modeling the effects of latency reversing drugs during HIV-1 and SIV brain infection with implications for the ``shock and kill strategy
- Analysis of HIV models with two time delays
- An HIV model with age-structured latently infected cells
- Mathematical analysis of an HIV latent infection model including both virus-to-cell infection and cell-to-cell transmission
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Modeling Pharmacodynamics on HIV Latent Infection: Choice of Drugs is Key to Successful Cure via Early Therapy
This page was built for publication: Analysis of HIV latent infection model with multiple infection stages and different drug classes
